Current Research in Translational Medicine

Papers
(The TQCC of Current Research in Translational Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Endovesical instillation of Cidofovir in the treatment of BK polyomavirus hemorrhagic cystitis after allogeneic hematopoietic cell transplantation25
Performances of the H-score and the HLH-2004 score in the positive diagnosis of secondary hemophagocytic lymphohistiocytosis23
Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFC18
Management of Philadelphia chromosome positive acute lymphoblastic leukemia in the current era16
Editorial board14
Feasibility of co-transplantation of umbilical cord blood and third-party mesenchymal stromal cells after (non)myeloablative conditioning in patients with hematological malignancies13
Association of Normal and Mutated APOL1 G2 Rs60910145 alleles with SCD, Body Mass Index, and Renal Function Biomarkers and Indices13
Plasma-derived extracellular vesicles from myocardial infarction patients inhibits tumor necrosis factor-alpha induced cardiac cell death12
Lactate level is an independent predictor of mortality in patients with hematologic malignancy receiving urgent chemotherapy in intensive care unit12
Luspatercept for the treatment of congenital sideroblastic anemia: Two case reports10
A novel MPIG6B gene mutation in an adolescent girl with congenital thrombocytopenia and myelofibrosis10
CRISPR-Cas9: A Prominent Genome Editing Tool in the Management of Inherited Blood Disorders and Hematological Malignancies10
Editorial board9
Catechol-O-methyltransferase gene (COMT) is associated with neurocognitive functioning in patients with sickle cell disease8
Cytogenetics in the management of hematological malignancies: An overview of alternative technologies for cytogenetic characterization8
Timing of cyclosporine administration for GvHD prophylaxis in haploidentical stem cell transplantation setting: Single center experience8
WITHDRAWN: Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetic body to induce macrophage polarization and inhibit erythrocyte damage7
Optimizing CAR-T cell function in solid tumor microenvironment: insights from culture media additives7
Establishment and characterization of a novel breast implant-associated anaplastic large cell lymphoma cell line and PDX model (BIA-XR1) with a unique KRAS mutation7
Editorial board7
CLSPN is a potential biomarker associated with poor prognosis in low-grade gliomas based on a multi-database analysis7
mRNA-lncRNA gene expression signature for predicting pediatric AML relapse6
Cytogenetics in the management of mature B-cell non-Hodgkin lymphomas: Guidelines from the Groupe Francophone de Cytogénétique Hematologique (GFCH)6
Construction of a stromal-related prognostic model in acute myeloid leukemia by comprehensive bioinformatics analysis6
Impaired survival of patients with non donor-specific anti-HLA antibodies before HLA-mismatched allogeneic stem cell transplantation6
Pneumonia definition in allogeneic hematopoietic cell transplant recipients: Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization a6
Perspectives on the use and availability of chimeric antigen receptor T cells (CAR-T) and cell therapies: A worldwide cross-sectional survey by the worldwide network for blood and marrow transplantati6
Letter to the editor regarding “Bone mineral density, osteopenia, osteoporosis, and fracture risk in patients with atopic dermatitis: A systematic review and meta-analysis”5
Contents5
Thanks to reviewers5
AI-assisted computational screening and docking simulation prioritize marine natural products for small-molecule PCSK9 inhibition5
Contents4
Therapeutic promise of CRISPR-Cas9 gene editing in sickle cell disease and β-thalassemia: A current review4
Contents4
Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression4
Sofosbuvir (+) daclatasvir (+) ribavirin in Egyptian patients with hepatitis C virus: Therapeutic outcomes and the prognostic role of natural killer cells4
Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)4
Exploring clues pointing toward the existence of a brain-gut microbiota-hair follicle axis4
Exosomal miR-195 in hUC-MSCs alleviates hypoxia-induced damage of trophoblast cells through tissue factor pathway inhibitor 24
Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)3
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type3
Caspases in PANoptosis3
New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemia3
Contents3
Effect and safety of recombinant human thrombopoietin on haematopoietic reconstitution after allogeneic haematopoietic cell transplantation3
Genetic diversity and expression profile of Plasmodium falciparum Pf34 gene supports its immunogenicity3
Trends in drug repurposing: Advancing cardiovascular disease management in geriatric populations3
Editorial board3
Early prediction of renal graft function: Analysis of a multi-center, multi-level data set3
Allogeneic hematopoietic stem cell transplantation in 18 patients with atypical inherited bone marrow failure syndromes: Efficacy and long-term outcomes3
Heparin beyond anti-coagulation3
Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)3
Editorial board3
Clinical image: A new category of articles in current research in translational medicine3
The transplantation effect of pegylated granulocyte colony-stimulating factor mobilized hematopoietic stem cells may be superior to that of G-CSF mobilized hematopoietic stem cells in haploidentical a3
FGF10/FGF17 as prognostic and drug response markers in acute myeloid leukemia3
Diagnostic and management strategies for Myeloproliferative Neoplasm-Unclassifiable (MPN-U): An international survey of contemporary practice3
0.090214014053345